Coinhibitory receptor PD-1H preferentially suppresses CD4+ T cell-mediated immunity

被引:230
作者
Flies, Dallas B.
Han, Xue
Higuchi, Tomoe
Zheng, Linghua
Sun, Jingwei
Ye, Jessica Jane
Chen, Lieping
机构
[1] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA
[2] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA
关键词
SURFACE SIGNALING MOLECULES; CONCANAVALIN-A; LIVER-INJURY; CANCER; ANTIBODY; STIMULATION; RADIATION; SAFETY; MODELS;
D O I
10.1172/JCI74589
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
T cell activation is regulated by the interactions of surface receptors with stimulatory and inhibitory ligands. Programmed death-1 homolog (PD-1H, also called VISTA) is a member of the CD28 family of proteins and has been shown to act as a coinhibitory ligand. on APCs that suppress T cell responses. Here, we determined that PD-1H functions as a coinhibitory receptor for CD4(+) T cells. CD4+ T cells in mice lacking PD-1H exhibited a dramatically increased response to antigen stimulation. Furthermore, delivery of a PD-1H-specific agonist mAb directly inhibited CD4(+) T cell activation both in vitro and in vivo, validating a coinhibitory function of PD-1H. In a murine model of acute hepatitis, administration of a PD-1H agonist mAb suppressed CD4(+) T cell-mediated acute inflammation. PD-1H-deficient animals were highly resistant to tumor induction in a murine brain glioma model, and depletion of CD4(+) T cells, but not CD8(+) T cells, promoted tumor formation. Together, our findings suggest that PD-1H has potential as a target of immune modulation in the treatment of human inflammation and malignancies.
引用
收藏
页码:1966 / 1975
页数:10
相关论文
共 20 条
  • [1] Extended Co-Expression of Inhibitory Receptors by Human CD8 T-Cells Depending on Differentiation, Antigen-Specificity and Anatomical Localization
    Baitsch, Lukas
    Legat, Amandine
    Barba, Leticia
    Marraco, Silvia A. Fuertes
    Rivals, Jean-Paul
    Baumgaertner, Petra
    Christiansen-Jucht, Celine
    Bouzourene, Hanifa
    Rimoldi, Donata
    Pircher, Hanspeter
    Rufer, Nathalie
    Matter, Maurice
    Michielin, Olivier
    Speiser, Daniel E.
    [J]. PLOS ONE, 2012, 7 (02):
  • [2] Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
    Brahmer, Julie R.
    Tykodi, Scott S.
    Chow, Laura Q. M.
    Hwu, Wen-Jen
    Topalian, Suzanne L.
    Hwu, Patrick
    Drake, Charles G.
    Camacho, Luis H.
    Kauh, John
    Odunsi, Kunle
    Pitot, Henry C.
    Hamid, Omid
    Bhatia, Shailender
    Martins, Renato
    Eaton, Keith
    Chen, Shuming
    Salay, Theresa M.
    Alaparthy, Suresh
    Grosso, Joseph F.
    Korman, Alan J.
    Parker, Susan M.
    Agrawal, Shruti
    Goldberg, Stacie M.
    Pardoll, Drew M.
    Gupta, Ashok
    Wigginton, Jon M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) : 2455 - 2465
  • [3] IL-6, IFN-γ and TNF-α production by liver-associated T cells and acute liver injury in rats administered concanavalin A
    Cao, Q
    Batey, R
    Pang, G
    Russell, A
    Clancy, R
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 1998, 76 (06) : 542 - 549
  • [4] Molecular mechanisms of T cell co-stimulation and co-inhibition
    Chen, Lieping
    Flies, Dallas B.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2013, 13 (04) : 227 - 242
  • [5] The role of NKT cells in animal models of autoimmune hepatitis
    Dennert, Gunther
    Aswad, Fred
    [J]. CRITICAL REVIEWS IN IMMUNOLOGY, 2006, 26 (05) : 453 - 473
  • [6] Durante M, 2013, TRENDS MOL MED, V19, P565, DOI 10.1016/j.molmed.2013.05.007
  • [7] Cutting Edge: A Monoclonal Antibody Specific for the Programmed Death-1 Homolog Prevents Graft-versus-Host Disease in Mouse Models
    Flies, Dallas B.
    Wang, Shengdian
    Xu, Haiying
    Chen, Lieping
    [J]. JOURNAL OF IMMUNOLOGY, 2011, 187 (04) : 1537 - 1541
  • [8] The clinical utility of inhibiting CD28-mediated costimulation
    Linsley, Peter S.
    Nadler, Steven G.
    [J]. IMMUNOLOGICAL REVIEWS, 2009, 229 : 307 - 321
  • [9] Liu Shu-Zheng, 2007, Dose-Response, V5, P39, DOI 10.2203/dose-response.06-108.Liu
  • [10] Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model
    Maes, Wim
    Van Gool, Stefaan W.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (02) : 153 - 160